Literature DB >> 16220491

The effects of non-compliance on intent-to-treat analysis of equivalence trials.

Dan Sheng1, Mimi Y Kim.   

Abstract

The standard approach for analysing a randomized clinical trial is based on intent-to-treat (ITT) where subjects are analysed according to their assigned treatment group regardless of actual adherence to the treatment protocol. For therapeutic equivalence trials, it is a common concern that an ITT analysis increases the chance of erroneously concluding equivalence. In this paper, we formally investigate the impact of non-compliance on an ITT analysis of equivalence trials with a binary outcome. We assume 'all-or-none' compliance and independence between compliance and the outcome. Our results indicate that non-compliance does not always make it easier to demonstrate equivalence. The direction and magnitude of changes in the type I error rate and power of the study depend on the patterns of non-compliance, event probabilities, the margin of equivalence and other factors. Copyright 2005 John Wiley & Sons, Ltd.

Mesh:

Year:  2006        PMID: 16220491     DOI: 10.1002/sim.2230

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  12 in total

1.  Evaluation of the Mental Healthiness Aging Initiative: community program to promote awareness about mental health and aging issues.

Authors:  Faika Zanjani; Tina Kruger; Deborah Murray
Journal:  Community Ment Health J       Date:  2011-01-14

Review 2.  Recommendations for improving the design, conduct, and analysis of clinical trials in hospital-acquired pneumonia and ventilator-associated pneumonia.

Authors:  John H Powers
Journal:  Clin Infect Dis       Date:  2010-08-01       Impact factor: 9.079

Review 3.  How the EMERGE guideline on medication adherence can improve the quality of clinical trials.

Authors:  Lina Eliasson; Sarah Clifford; Amy Mulick; Christina Jackson; Bernard Vrijens
Journal:  Br J Clin Pharmacol       Date:  2020-02-28       Impact factor: 4.335

4.  Modified intention to treat reporting in randomised controlled trials: systematic review.

Authors:  Iosief Abraha; Alessandro Montedori
Journal:  BMJ       Date:  2010-06-14

Review 5.  Room for improvement in conducting and reporting non-inferiority randomized controlled trials on drugs: a systematic review.

Authors:  Grace Wangge; Olaf H Klungel; Kit C B Roes; Anthonius de Boer; Arno W Hoes; Mirjam J Knol
Journal:  PLoS One       Date:  2010-10-27       Impact factor: 3.240

6.  Methodology of clinical trials aimed at assessing interventions for cutaneous leishmaniasis.

Authors:  Piero Olliaro; Michel Vaillant; Byron Arana; Max Grogl; Farrokh Modabber; Alan Magill; Olivier Lapujade; Pierre Buffet; Jorge Alvar
Journal:  PLoS Negl Trop Dis       Date:  2013-03-21

7.  Allowing for missing outcome data and incomplete uptake of randomised interventions, with application to an Internet-based alcohol trial.

Authors:  Ian R White; Eleftheria Kalaitzaki; Simon G Thompson
Journal:  Stat Med       Date:  2011-09-21       Impact factor: 2.373

8.  Treatment crossovers in time-to-event non-inferiority randomised trials of radiotherapy in patients with breast cancer.

Authors:  Sameer Parpia; Jim A Julian; Lehana Thabane; Chushu Gu; Timothy J Whelan; Mark N Levine
Journal:  BMJ Open       Date:  2014-10-24       Impact factor: 2.692

Review 9.  Empirical Consequences of Current Recommendations for the Design and Interpretation of Noninferiority Trials.

Authors:  Scott K Aberegg; Andrew M Hersh; Matthew H Samore
Journal:  J Gen Intern Med       Date:  2017-09-05       Impact factor: 5.128

10.  Estimating treatment effects in randomised controlled trials with non-compliance: a simulation study.

Authors:  Chenglin Ye; Joseph Beyene; Gina Browne; Lehana Thabane
Journal:  BMJ Open       Date:  2014-06-17       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.